Mesa Laboratories Inc (MLAB)
Debt-to-capital ratio
| Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | — | 155,214 | 161,451 | 150,727 | 145,393 | 402,961 | 387,759 | 387,719 | 393,480 | 387,205 | 374,236 | 380,431 | 393,801 | 396,329 | 399,417 | 399,003 | 406,227 | 412,795 | 392,412 | 382,234 |
| Debt-to-capital ratio | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
March 31, 2025 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $—K)
= —
The debt-to-capital ratio of Mesa Laboratories Inc, as provided in the data, has consistently been reported as 0.00 from June 30, 2020, to March 31, 2025. This indicates that the company has not had any long-term debt in its capital structure during this period.
A debt-to-capital ratio of 0.00 implies that Mesa Laboratories Inc has not relied on debt financing to fund its operations or expansion activities. Instead, the company has primarily used equity financing or retained earnings to support its growth and investment initiatives. This can be viewed positively by investors and creditors as it suggests a lower level of financial risk since there is no debt to service or repay.
Overall, the stable and consistently low debt-to-capital ratio of 0.00 for Mesa Laboratories Inc reflects a conservative financial strategy that prioritizes a strong equity base and financial stability.
Peer comparison
Mar 31, 2025